The US Food and Drug Administration has missed its latest deadline to propose banning formaldehyde and certain formaldehyde-releasing chemicals from hair-straightening products, often used by Black ...

The Procter & Gamble (P&G)-owned brand will support Team USA athletes in the extreme winter conditions by providing hydrating ...

South Korea’s president has sparked debate after suggesting public healthcare should cover hair loss treatment for male ...

One man is stocking up on cupping kits for his home spa. In Seattle, a fitness buff is paying for yoga classes, ski passes ...

Finasteride affects the hormones involved with male pattern baldness. Finasteride may help slow hair loss at your hairline, ...

Scalp micropigmentation has become a trusted option for individuals seeking a non-surgical way to improve the appearance of hair loss.

Research supports that both finasteride and dutasteride help treat hair loss, particularly when caused by androgenetic ...

A new experimental hair-loss treatment has sent Cosmo Pharmaceuticals' stock soaring. But doctors say the drug is promising, ...

Doctors Ben and Sean Behnam built an alternative to one-size-fits-all solutions with their new company, Happy Head.

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Thinning hair isn’t just a cosmetic concern — it’s a confidence ...

Men confronting a receding hairline traditionally have had few choices. Minoxidil and finasteride, the stalwarts of hair-loss treatment, arrived in the 1980s and 1990s. Since then, little has changed.

A new experimental scalp treatment called clascoterone has shown strong results in helping reduce male-pattern hair loss (also known as androgenetic alopecia, or AGA). Experts call the results ...